video corpo
  • Products
  • Catalogs
  • News & Trends
  • Exhibitions

Ophthalmoscopy software Med®-Fundus AI™

ophthalmoscopy software
ophthalmoscopy software
ophthalmoscopy software
ophthalmoscopy software
ophthalmoscopy software
ophthalmoscopy software
Add to favorites
Compare this product


Application domain
for ophthalmoscopy
diagnostic, screening


VUNO Med-Fundus AI provides major findings necessary for the diagnosis of retinal diseases based on fundus images. AI-based diagnostic supporting solution for the fundus of the eye Korea's first innovative medical device MFDS(K-FDA) approved CE Certified Workflow Improvement It helps intuitively check the presence of 12 abnormalities and locate them. Drusen Hemorrhage Hard Exudate Cotton Wool Patch Vascular Abnormality Glaucomatous Disc Change RNFL Defect Membrane Chroioretinal Atrophy Non-glaucomatous Disc Change Macular Hole Myelinated Nerve Fiber Ready to Support The software automatically locates optic discs and macula to mark eight regions of the fundus* and help diagnose the drawn regions. Macular Superior optic disc Inferior optic disc Temporal Superotemporal Inferotemporal Superonasal Inferonasal Training Dataset Based on a total of 103,262 fundus images on which 57 ophthalmologists* executed a triple reading, the diagnostic supporting system detects abnormalities in fundus images. * 16 retina specialists, 9 glaucoma specialists and 3 corneal specialists References 1. Son J, et al. Development and Validation of Deep Learning Models for Screening Multiple Abnormal Findings in Retinal Fundus Images.Ophthalmology (2019). Fundus AI Report VUNO Med-Fundus AI provides a patient report containing visualized abnormality findings that facilitates doctor-patient communication with enhanced patient satisfaction.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.